UPDATE: Piper Jaffray Raises PT to $50 on MAKO Surgical Corp

Piper Jaffray increases its price target on Overweight-rated MAKO Surgical Corp MAKO to $50, up $13, reflecting potential catalysts and fundamentals that should provide support to the company. Piper Jaffray says, "WE see potential positive catalysts including the potential approval of the new hip and new hospital network contracts. We also see compelling fundamental support for further upside, and we include in this report our updated scenario and discounted cash flow analysis as supplementary support for our investment thesis." MAKO closed at $38.83 a share on Friday.